3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
7
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Hematopoietic and Lymphoid System Neoplasm
3
Hematologic Neoplasms
3
Colorectal Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Malignant Solid Neoplasm
2
Head and Neck Carcinoma
2
Fallopian Tube Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Ureteral Neoplasms
1
Tonsillar Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Stomatitis
1
Spondylitis, Ankylosing
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Interventions
pembrolizumab
4
enfortumab vedotin
4
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
tamibarotene
1
Standard of Care
1
Radiotherapy
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Plasma Exchange
1
Nephroureterectomy
1
Morphine
1
Hyperthermia, Induced
1
Cystectomy
1
Cisplatin
1
Central Venous Catheters
1
Bupivacaine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Ureteral Neoplasms
×
Practice Guidelines as Topic
×
Clear all
NCT07087860
2026-05-08
RECIPE-B1
Mayo Clinic
Phase 2
Recruiting
70 enrolled